The relationship of intracellular iron chelation to the inhibition and regeneration of human ribonucleotide reductase

被引:165
|
作者
Cooper, CE
Lynagh, GR
Hoyes, KP
Hider, RC
Cammack, R
Porter, JB
机构
[1] UCL, SCH MED, DEPT HAEMATOL, LONDON WC1E 6HX, ENGLAND
[2] UNIV LONDON KINGS COLL, DIV LIFE SCI, MET BIOL & MED CTR, LONDON W8 7AH, ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1074/jbc.271.34.20291
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The depletion of cellular iron can lead to the inhibition of ribonucleotide reductase, preventing new DNA synthesis and hence inhibiting cell proliferation. Electron paramagnetic resonance (EPR) spectroscopy has been used to examine simultaneously for the first time the relationship between chelation of intracellular iron and the rate of removal and regeneration of the tyrosyl radical of ribonucleotide reductase within intact human leukemia K562 cells. The different physiochemical characteristics of relatively hydrophobic low molecular weight bidentate hydroxypyridinone chelators and the higher molecular weight hexadentate ferrioxamine have been exploited to elucidate these interactions further. The base-line concentration of EPR detectable mononuclear nonheme iron complexes was 3.15 +/- 1.05 mu M, rising on incubation with chelators more rapidly with hydroxypyridinones than with desferrioxamine. Hydroxypyridinones also removed the tyrosyl radical more rapidly, apparently as a consequence of depletion of the intracellular iron pools necessary to regenerate the active enzyme and compatible with their reportedly greater cell toxicity. The radical decay rate is consistent with previous models, suggesting that iron is spontaneously removed from mammalian ribonucleotide reductase. Upon removal of extracellular chelator the regeneration of the tyrosyl radical was significantly faster for hydroxypyridinones than for desferrioxamine, consistent with their differential effects on cell cycle synchronization.
引用
收藏
页码:20291 / 20299
页数:9
相关论文
共 50 条
  • [21] PURIFICATION AND CHARACTERIZATION OF HUMAN RIBONUCLEOTIDE REDUCTASE
    CHANG, CH
    CHENG, YC
    PHARMACOLOGIST, 1977, 19 (02): : 151 - 151
  • [22] THE IRON-METABOLISM OF THE HUMAN NEUROBLASTOMA CELL - LACK OF RELATIONSHIP BETWEEN THE EFFICACY OF IRON CHELATION AND THE INHIBITION OF DNA-SYNTHESIS
    RICHARDSON, DR
    PONKA, P
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1994, 124 (05): : 660 - 671
  • [23] DIFFERENTIAL MECHANISMS OF INHIBITION OF RIBONUCLEOTIDE REDUCTASE BY SPECIFIC INHIBITORS OF THE NON-HEME IRON SUBUNIT
    CORY, JG
    SATO, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 17 - 17
  • [24] RIBONUCLEOTIDE REDUCTASE - AN INTRACELLULAR TARGET FOR THE MALE ANTIFERTILITY AGENT, GOSSYPOL
    MCCLARTY, GA
    CHAN, AK
    CREASEY, DC
    WRIGHT, JA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 133 (01) : 300 - 305
  • [25] EXAFS OF BINUCLEAR IRON PROTEINS - HEMERYTHRIN AND RIBONUCLEOTIDE REDUCTASE
    SCARROW, RC
    MARONEY, MJ
    PALMER, SM
    QUE, L
    ROE, AL
    SALOWE, SP
    STUBBE, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 192 : 254 - INOR
  • [26] RIBONUCLEOTIDE REDUCTASE A STRUCTURAL STUDY OF THE DIMERIC IRON SITE
    SJOBERG, BM
    GRASLUND, A
    LOEHR, JS
    LOEHR, TM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1980, 94 (03) : 793 - 799
  • [27] Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase
    Roman, Nicholas O.
    Samulitis, Betty K.
    Wisner, Lee
    Landowski, Terry H.
    Dorr, Robert T.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (01) : 183 - 192
  • [28] Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase
    Nicholas O. Roman
    Betty K. Samulitis
    Lee Wisner
    Terry H. Landowski
    Robert T. Dorr
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 183 - 192
  • [29] Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd)
    Avval, Farnaz Zahedi
    Berndt, Carsten
    Pramanik, Aladdin
    Holmgren, Arne
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (03) : 775 - 779
  • [30] POTENTIATION OF ANTIHERPETIC ACTIVITY OF ACYCLOVIR BY RIBONUCLEOTIDE REDUCTASE INHIBITION
    SPECTOR, T
    AVERETT, DR
    NELSON, DJ
    LAMBE, CU
    MORRISON, RW
    STCLAIR, MH
    FURMAN, PA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (12) : 4254 - 4257